Trinity Biotech (TRIB) Competitors $0.65 -0.02 (-3.48%) As of 12:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TRIB vs. AADI, NBRV, ANEB, MURA, ALGS, RNTX, CNTB, SCLX, ATHE, and BDRXShould you be buying Trinity Biotech stock or one of its competitors? The main competitors of Trinity Biotech include Aadi Bioscience (AADI), Nabriva Therapeutics (NBRV), Anebulo Pharmaceuticals (ANEB), Mural Oncology (MURA), Aligos Therapeutics (ALGS), Rein Therapeutics (RNTX), Connect Biopharma (CNTB), Scilex (SCLX), Alterity Therapeutics (ATHE), and Biodexa Pharmaceuticals (BDRX). These companies are all part of the "pharmaceutical products" industry. Trinity Biotech vs. Its Competitors Aadi Bioscience Nabriva Therapeutics Anebulo Pharmaceuticals Mural Oncology Aligos Therapeutics Rein Therapeutics Connect Biopharma Scilex Alterity Therapeutics Biodexa Pharmaceuticals Aadi Bioscience (NASDAQ:AADI) and Trinity Biotech (NASDAQ:TRIB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, community ranking, analyst recommendations, media sentiment, dividends and institutional ownership. Is AADI or TRIB more profitable? Trinity Biotech has a net margin of -34.39% compared to Aadi Bioscience's net margin of -246.06%. Trinity Biotech's return on equity of 0.00% beat Aadi Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Aadi Bioscience-246.06% -71.87% -57.28% Trinity Biotech -34.39%N/A -21.37% Does the MarketBeat Community prefer AADI or TRIB? Trinity Biotech received 324 more outperform votes than Aadi Bioscience when rated by MarketBeat users. Likewise, 69.79% of users gave Trinity Biotech an outperform vote while only 39.29% of users gave Aadi Bioscience an outperform vote. CompanyUnderperformOutperformAadi BioscienceOutperform Votes1139.29% Underperform Votes1760.71% Trinity BiotechOutperform Votes33569.79% Underperform Votes14530.21% Do institutionals & insiders have more ownership in AADI or TRIB? 52.1% of Aadi Bioscience shares are held by institutional investors. Comparatively, 79.0% of Trinity Biotech shares are held by institutional investors. 37.3% of Aadi Bioscience shares are held by company insiders. Comparatively, 8.2% of Trinity Biotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, AADI or TRIB? Aadi Bioscience has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, Trinity Biotech has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Do analysts rate AADI or TRIB? Aadi Bioscience presently has a consensus price target of $1.67, suggesting a potential downside of 18.30%. Given Aadi Bioscience's stronger consensus rating and higher possible upside, research analysts clearly believe Aadi Bioscience is more favorable than Trinity Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aadi Bioscience 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Trinity Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher earnings and valuation, AADI or TRIB? Trinity Biotech has higher revenue and earnings than Aadi Bioscience. Aadi Bioscience is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAadi Bioscience$25.07M2.01-$65.76M-$2.35-0.87Trinity Biotech$61.56M0.19-$24.02M-$2.82-0.23 Does the media refer more to AADI or TRIB? In the previous week, Trinity Biotech had 1 more articles in the media than Aadi Bioscience. MarketBeat recorded 1 mentions for Trinity Biotech and 0 mentions for Aadi Bioscience. Trinity Biotech's average media sentiment score of 1.87 beat Aadi Bioscience's score of 0.00 indicating that Trinity Biotech is being referred to more favorably in the news media. Company Overall Sentiment Aadi Bioscience Neutral Trinity Biotech Very Positive SummaryTrinity Biotech beats Aadi Bioscience on 12 of the 17 factors compared between the two stocks. Get Trinity Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TRIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRIB vs. The Competition Export to ExcelMetricTrinity BiotechDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.68M$2.70B$5.62B$8.58BDividend YieldN/A0.70%5.28%4.17%P/E Ratio-0.297.8027.1919.81Price / Sales0.1934.51408.23154.60Price / CashN/A15.7538.3234.64Price / Book-0.215.386.994.65Net Income-$24.02M-$65.73M$3.23B$248.05M7 Day Performance-1.22%-3.28%-0.18%-0.26%1 Month Performance-14.46%-0.11%8.61%4.37%1 Year Performance-81.35%-20.87%32.26%13.65% Trinity Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRIBTrinity Biotech1.8012 of 5 stars$0.65-3.5%N/A-76.2%$11.68M$61.56M-0.29480Positive NewsAADIAadi Bioscience0.6029 of 5 stars$1.87+11.3%$1.67-10.9%+17.6%$46.18M$25.07M-0.8240NBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070ANEBAnebulo Pharmaceuticals3.103 of 5 stars$1.10+1.9%$5.50+400.0%-40.1%$45.19MN/A-3.934Positive NewsGap DownMURAMural Oncology3.3204 of 5 stars$2.61+2.0%$13.00+398.1%-25.4%$45.07MN/A-0.29119News CoverageShort Interest ↓ALGSAligos Therapeutics4.6311 of 5 stars$7.19-0.1%$70.00+873.6%-37.0%$43.96M$3.27M-0.5490News CoveragePositive NewsGap DownRNTXRein TherapeuticsN/A$1.98-1.0%N/AN/A$43.87MN/A-0.639News CoverageGap DownCNTBConnect Biopharma3.5882 of 5 stars$0.78-1.3%$8.00+924.3%-52.0%$43.39M$26.03M0.00110News CoveragePositive NewsAnalyst ForecastSCLXScilex2.3881 of 5 stars$6.18-2.1%$455.00+7,262.5%-89.7%$42.96M$50.71M-7.4580Positive NewsHigh Trading VolumeATHEAlterity Therapeutics2.1439 of 5 stars$4.84+2.3%$12.00+147.9%+136.6%$42.92MN/A0.0010BDRXBiodexa Pharmaceuticals0.4866 of 5 stars$1.15flatN/AN/A$42.03M$83K0.0020Short Interest ↑ Related Companies and Tools Related Companies Aadi Bioscience Competitors Nabriva Therapeutics Competitors Anebulo Pharmaceuticals Competitors Mural Oncology Competitors Aligos Therapeutics Competitors Rein Therapeutics Competitors Connect Biopharma Competitors Scilex Competitors Alterity Therapeutics Competitors Biodexa Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TRIB) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TRIB Stock Free TRIB Stock Alerts